comparemela.com
Home
Live Updates
NeuroSense Therapeutics Receives $4 Million Through Warrant Exercises : comparemela.com
NeuroSense Therapeutics Receives $4 Million Through Warrant Exercises
/PRNewswire/ -- NeuroSense Therapeutics Ltd. (Nasdaq: NRSN) ("NeuroSense"), a company developing treatments for severe neurodegenerative diseases, today...
Related Keywords
Cambridge ,
Cambridgeshire ,
United Kingdom ,
,
Linkedin ,
Twitter ,
European Medicines Agency ,
Nasdaq ,
Neurosense Therapeutics Ltd ,
Neurosense Therapeutics ,
Orphan Drug Designation ,
Sense Therapeutics ,
Neurosense ,
Health Care Amp Hospitals ,
Medical Pharmaceuticals ,
Biotechnology ,
Accounting News Amp Issues ,
comparemela.com © 2020. All Rights Reserved.